3CPLro-IN-1
3CPLro-IN-1 (compound A17) is a potent and orally active inhibitor of SARS-CoV-2 3CLpro with an IC50 of 5.65 μM. 3-Chymotrypsin-like cysteine protease (3CLpro) is an indispensable protein in viral replication and represents an attractive agent target for fighting COVID-19[1].
Product Specifications
CAS Number
2432956-06-2
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/3cplro-in-1.html
Solubility
10 mM in DMSO
Smiles
O=C(C)OCC1C2=C(C)C=CC(O)=C2C3=CC=CC(C4=NC=CC(C5=CC=CC=C5)=C4)=C3C1
Molecular Formula
C29H25NO3
Molecular Weight
435.51
References & Citations
[1]Zhang JW, et al. Discovery of 9,10-dihydrophenanthrene derivatives as SARS-CoV-2 3CLpro inhibitors for treating COVID-19. Eur J Med Chem. 2022;228:114030.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC682593-100 1x 100 µL
Cyclin D1 (G1-Cyclin & Mantle Cell Lymphoma Marker) (CCND1/2593), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
AP32957PU-N 100 µg
p15 INK4b (CDKN2B) (Isoform 2) (C-term) Goat Polyclonal Antibody
Sign In for Pricing
View Details 